Citation: | ZHANG Jing, LIU Xin, XU Chun. Analysis of the progress and research hotspots of “Pharmacology and Toxicology” in Chinese universities based on the databases[J]. Journal of China Pharmaceutical University, 2020, 51(6): 748-758. DOI: 10.11665/j.issn.1000-5048.20200615 |
[1] |
.(
|
[2] |
Hu JH. The influence of “Double First-class” construction on the discipline development in China''''s universities[J]. Jiangsu Higher Educ(江苏高教),2018(7):5?8,13.
|
[3] |
Zhang JL,Chen TZ. On the discipline development planning in the construction of “Double First-Class”:strategy,management,and effectiveness—case studies of two institutions building into world-class universities[J]. China Higher Educ Res(中国高教研究),2018(7):22?29.
|
[4] |
Liu BH,Zhang HR,Wang HW. The contrastive analysis of mathematical subject data based on ESI and thoughts on discipline construction—taking the mathematics of Wuhan University as an example[J]. Document Inform Knowl(图书情报知识),2017(1):114?122.
|
[5] |
Song LP,Wang JF. An empirical study of scientific evaluation based on the correlation between CNCI and peer review[J]. Lib Inform Ser(图书情报工作),2018,62(18):122?128.
|
[6] |
Yang FJ,Liang Z,Xue L,et al. Assessing the effects of the Chinese state key laboratory initiative[J]. Sci Sci Managem S& T(科学学与科学技术管理),2019,40(2):26?39.
|
[7] |
Ding S. Analysis on the influencing factors of scientific research development in affiliated hospitals of colleges and universities and countermeasures[C].
|
[8] |
Shen TP,Yang ST,Chu JW. Hotspot of knowledge chain research based on the co-words analysis[J]. New Cent Lib(新世纪图书馆),2014(1):88?92.
|
[9] |
Mao SR,Sun W,Kissel T. Chitosan-based formulations for delivery of DNA and siRNA[J]. Adv Drug Deliv Rev,2010,62(1):12?27.
|
[10] |
Banerjee A,Qi JP,Gogoi R,et al. Role of nanoparticle size,shape and surface chemistry in oral drug delivery[J]. J Control Release,2016,238:176?185.
|
[11] |
Zhang SY,Liu YJ,Gan Y,et al. Conjugates of TAT and folate with DOX-loaded chitosan micelles offer effective intracellular delivery ability[J]. Pharm Dev Technol,2019,24(2):253?261.
|
[12] |
Wei X,Yang X,Han ZP,et al. Mesenchymal stem cells:a new trend for cell therapy[J]. Acta Pharm Sin(药学学报),2013,34(6):747?754.
|
[13] |
Chen XM,Song EW. Turning foes to friends:targeting cancer-associated fibroblasts[J]. Nat Rev Drug Discov,2019,18(2):99?115.
|
[14] |
Guo ZR. The modification of natural products for medical use[J]. Acta Pharma Sin B,2017,7(2):119?136.
|
[15] |
Williamson EM,Liu XM,Izzo AA. Trends in use,pharmacology,and clinical applications of emerging herbal nutraceuticals[J]. Brit J Pharmacol,2020,177(6):1227?1240.
|
[16] |
Zhang Y,Huo MR,Zhou JP. et al. DDSolver:an add-in program for modeling and comparison of drug dissolution profiles[J]. The AAPS J,2010,12(3):263?271.
|